London · Delayed Price · Currency is GBP · Price in GBX CTI BioPharma Statistics
Total Valuation
Wickes Group has a market cap or net worth of GBP 514.93 million. The enterprise value is 1.14 billion.
| Market Cap | 514.93M |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Apr 24, 2025 |
Share Statistics
Wickes Group has 237.29 million shares outstanding. The number of shares has decreased by -4.24% in one year.
| Current Share Class | 237.29M |
| Shares Outstanding | 237.29M |
| Shares Change (YoY) | -4.24% |
| Shares Change (QoQ) | -1.44% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 88.62% |
| Float | 212.60M |
Valuation Ratios
The trailing PE ratio is 28.93 and the forward PE ratio is 13.97. Wickes Group's PEG ratio is 0.59.
| PE Ratio | 28.93 |
| Forward PE | 13.97 |
| PS Ratio | 0.33 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | 3.75 |
| P/OCF Ratio | 3.18 |
| PEG Ratio | 0.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.85, with an EV/FCF ratio of 8.26.
| EV / Earnings | 62.71 |
| EV / Sales | 0.74 |
| EV / EBITDA | 6.85 |
| EV / EBIT | 17.04 |
| EV / FCF | 8.26 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 4.82.
| Current Ratio | 1.14 |
| Quick Ratio | 0.46 |
| Debt / Equity | 4.82 |
| Debt / EBITDA | 4.26 |
| Debt / FCF | 5.13 |
| Interest Coverage | 2.19 |
Financial Efficiency
Return on equity (ROE) is 11.88% and return on invested capital (ROIC) is 4.92%.
| Return on Equity (ROE) | 11.88% |
| Return on Assets (ROA) | 3.87% |
| Return on Invested Capital (ROIC) | 4.92% |
| Return on Capital Employed (ROCE) | 8.62% |
| Revenue Per Employee | 197,942 |
| Profits Per Employee | 2,328 |
| Employee Count | 7,774 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 5.01 |
Taxes
In the past 12 months, Wickes Group has paid 4.80 million in taxes.
| Income Tax | 4.80M |
| Effective Tax Rate | 20.69% |
Stock Price Statistics
The stock price has increased by +43.71% in the last 52 weeks. The beta is 0.92, so Wickes Group's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +43.71% |
| 50-Day Moving Average | 224.29 |
| 200-Day Moving Average | 182.35 |
| Relative Strength Index (RSI) | 40.38 |
| Average Volume (20 Days) | 764,797 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Wickes Group had revenue of GBP 1.54 billion and earned 18.10 million in profits. Earnings per share was 0.08.
| Revenue | 1.54B |
| Gross Profit | 565.10M |
| Operating Income | 66.60M |
| Pretax Income | 23.20M |
| Net Income | 18.10M |
| EBITDA | 88.90M |
| EBIT | 66.60M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 86.30 million in cash and 705.30 million in debt, giving a net cash position of -619.00 million or -2.61 per share.
| Cash & Cash Equivalents | 86.30M |
| Total Debt | 705.30M |
| Net Cash | -619.00M |
| Net Cash Per Share | -2.61 |
| Equity (Book Value) | 146.40M |
| Book Value Per Share | 0.60 |
| Working Capital | 44.30M |
Cash Flow
In the last 12 months, operating cash flow was 162.00 million and capital expenditures -24.60 million, giving a free cash flow of 137.40 million.
| Operating Cash Flow | 162.00M |
| Capital Expenditures | -24.60M |
| Free Cash Flow | 137.40M |
| FCF Per Share | 0.58 |
Margins
Gross margin is 36.72%, with operating and profit margins of 4.33% and 1.18%.
| Gross Margin | 36.72% |
| Operating Margin | 4.33% |
| Pretax Margin | 1.51% |
| Profit Margin | 1.18% |
| EBITDA Margin | 5.78% |
| EBIT Margin | 4.33% |
| FCF Margin | 8.93% |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 4.92%.
| Dividend Per Share | 0.11 |
| Dividend Yield | 4.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 144.20% |
| Buyback Yield | 4.24% |
| Shareholder Yield | 9.16% |
| Earnings Yield | 3.52% |
| FCF Yield | 26.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Wickes Group has an Altman Z-Score of 3.09 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.09 |
| Piotroski F-Score | 6 |